Analysis

Biocon Limited (BIOCON) Stock Analysis

Biocon Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to BIOCON.

websiteBIOCON/analysis/BIOCON

Biocon Limited

Biocon Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to BIOCON.

Stock profile

Ticker

BIOCON

Asset type

Stock

Market cap

$7.10B

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

INR

Ticker listings

Biocon Limited may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • BIOCON primary listing

Latest Biocon Limited news

Press Release May 07 2026

Biocon Limited has informed the Exchange regarding a press release dated May 07, 2026, titled "Biocon Q4FY26 Total Income at Rs 4,569 Cr EBITDA at Rs 1,073 Cr; Net Profit (befor...

Press Release Apr 21 2026

Biocon Limited has informed the Exchange regarding a press release dated April 21, 2026, titled "Biocon Receives Health Canada Approval of Bosaya (Denosumab) and Vevzuo (Denosum...

Biocon Receives Health Canada Approval of Bosaya™ (Denosumab) and Vevzuo™ (Denosumab), Biosimilars to Prolia® and Xgeva®

TORONTO & BENGALURU, India, April 21, 2026--Biocon Receives Health Canada Approval of Bosaya™ and Vevzuo™ (Denosumab biosimilars to Prolia® and Xgeva®) for bone health.

Biocon Limited Press Release Apr 21 2026

Biocon Limited has informed the Exchange regarding a press release dated April 21, 2026, titled "Biocon Receives Health Canada Approval of Bosaya (Denosumab) and Vevzuo (Denosum...

Press Release Apr 07 2026

Biocon Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Biocon Announces U.S. Commercial Launch of Bosaya and Aukelso , Denosumab Biosim...

Research sections

Valuation

Review valuation context for Biocon Limited.

Future growth

Review future growth context for Biocon Limited.

Past performance

Review past performance context for Biocon Limited.

Financial health

Review financial health context for Biocon Limited.

Dividend

Review dividend context for Biocon Limited.

Management

Review management context for Biocon Limited.

Ownership

Review ownership context for Biocon Limited.

Other information

Review other information context for Biocon Limited.

Community

Review community context for Biocon Limited.